Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammato

Coronado Biosciences, Inc. , a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that Thomas F. Schaible, Ph.D. has joined the Company as Project Leader, Inflammatory Bowel Disease.


More...